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Propositions 
Clavis Aurea? 
Structure-enabled approaches of  
identifying and optimizing GPCR ligands 
 
1. We have entered the “golden era” of structure-based design for 
GPCRs. 
Chapters 1 and 2, this thesis. 
 
2. Traditionally water molecules have been neglected in 
computational chemistry, however they play a key role in ligand 
binding and unbinding. 
Chapters 1,2,3 and 8 this thesis 
 
3. Using GPUs in calculations has been an enabling technique in 
which speedups between 100 and 200 fold over regular CPUs 
are attained.  
Chapters 6 and 7, this thesis 
 
4. Finding molecules that are both novel and active is a 
challenging task for a well-studied target.  
Chapter 4, this thesis 
 
5. For the computational chemist, there is no “prototype”, or 
workflow that can predict all the relevant parameters. Applying 
multiple (complementary) techniques and making an informed 
decision is still the standard approach. 
Chapter 8, this thesis 
 
6. Heads up no-limit poker professionals have now also been 
beaten by artificial intelligence (neural networks), 
demonstrating that in multiple tasks AI is able to achieve 
“super-human” performance.  
Moravčík, M.; Schmid, M.; Burch, N.; Lisý, V.; Morrill, D.; Bard, N.; Davis, T.; 
Waugh, K.; Johanson, M.; Bowling, M., DeepStack: Expert-level artificial 
intelligence in heads-up no-limit poker. Science 2017. 
 
 7. In order to have an impact on hit discovery, models can exhibit 
an error of 5 log units in the predicted affinity, as long as they 
are capable of rapidly processing large numbers of compounds. 
For lead optimization this error should be around 1 log unit, 
thus requiring more robust models. 
Brown, S. P.; Muchmore, S. W.; Hajduk, P. J., Healthy skepticism: assessing 
realistic model performance. Drug Discovery Today 2009, 14, 420-427. 
 
8. Most protein crystal structures are produced under non-
physiological (cryo)conditions. Therefore there is a significant 
bias in structural databases towards smaller, overpacked 
models. Monitoring the (room-temperature) conformational 
ensembles might reveal interesting motions, which are for 
instance involved in ligand binding and allosteric regulation. 
Fraser, J. S.; van den Bedem, H.; Samelson, A. J.; Lang, P. T.; Holton, J. M.; Echols, 
N.; Alber, T., Accessing protein conformational ensembles using room-
temperature X-ray crystallography. Proc. Natl. Acad. Sci.U. S. A. 2011, 108, 16247-
16252. 
 
9. Unless dynamic information is used in structure-based drug 
design, it holds limited value. Optimizing drugs to purposefully 
mismatch the binding site, so called entropy-based optimization 
is an overlooked strategy.  
Fernández, A.; Fraser, C.; Scott, L. R., Purposely engineered drug–target 
mismatches for entropy-based drug optimization. Trends in Biotech. 2012, 30, 1-7. 
 
10. “To measure is to know”- “but you should know what you are 
measuring.”    Adapted quote from Lord Kelvin by Albert Lenselink 
 
11. “Wine makes all things possible”  
George R.R. Martin 
